These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 19833539)

  • 1. [Ovarian stimulation for IVF in France: choice and results according to protocols and gonadotrophin].
    Rossin B; Pouly JL; Belaisch-Allart J; de Mouzon J;
    Gynecol Obstet Fertil; 2009; 37(11-12):864-72. PubMed ID: 19833539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro fertilization in France: economic aspects and influence of the gonadotropin choice (urinary vs. recombinant) on cost].
    de Mouzon J; Allavena E; Schmitt C; Frappé M
    Gynecol Obstet Fertil; 2004 Jun; 32(6):508-18. PubMed ID: 15217566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of controlled ovarian stimulation for ART in poor responders according to the short protocol using different gonadotrophins combinations.
    Loutradis D; Elsheikh A; Kallianidis K; Drakakis P; Stefanidis K; Milingos S; Michalas S
    Arch Gynecol Obstet; 2004 Dec; 270(4):223-6. PubMed ID: 13680266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy outcome following in vitro fertilization-embryo transfer (IVF-ET) in women aged < 37, undergoing ovulation induction with human FSH compared with recombinant FSH: a randomised controlled study.
    Gholami H; Vicari E; Molis M; La Vignera S; Papaleo E; Cappiello F
    Eur Rev Med Pharmacol Sci; 2010 Feb; 14(2):97-102. PubMed ID: 20329567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
    Ku SY; Choi YS; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
    Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist flare protocols for poor responders undergoing in vitro fertilization.
    Berin I; Stein DE; Keltz MD
    Fertil Steril; 2010 Feb; 93(2):360-3. PubMed ID: 19131055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro fertilization in women over the age of 40].
    Belaïsch-Allart J; de Mouzon J; Bachelot A; Logerot-Lebrun H; Rufat P
    Contracept Fertil Sex; 1993 May; 21(5):367-70. PubMed ID: 7920918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of agonists versus antagonists for i.v.f. stimulation: the French FIVNAT survey 2001-2002].
    Pouly JL; Bachelot A; de Mouzon J; Devaux A;
    Gynecol Obstet Fertil; 2004 Sep; 32(9):737-40. PubMed ID: 15380755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical outcome of patients with follicular development retardation by prolonged duration of gonadotropin administration for in vitro fertilization].
    Chen SL; Sun L; Kong LH; Li L; Li J; Zhu L; Gao TM; Xing FQ
    Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):526-9. PubMed ID: 17983490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Falling FSH levels predict poor IVF pregnancy rates in patients whom the gonadotropins are withheld.
    Erman Akar M; Oktay K
    Arch Gynecol Obstet; 2009 Nov; 280(5):761-5. PubMed ID: 19255769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of ovulation induction protocols for in vitro fertilization].
    Geva E; Yovel I; Lessing JB; Yaron Y; Botchan A; David MP; Peyser MR; Amit A
    Harefuah; 1993 Sep; 125(5-6):129-33, 192. PubMed ID: 8225088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes.
    Weitzman VN; Engmann L; DiLuigi A; Maier D; Nulsen J; Benadiva C
    Fertil Steril; 2009 Jul; 92(1):226-30. PubMed ID: 18675961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled ovarian hyperstimulation: does prolonged stimulation justify cancellation of in vitro fertilization cycles?
    Bar-Hava I; Yoeli R; Yulzari-Roll V; Ashkenazi J; Shalev J; Orvieto R
    Gynecol Endocrinol; 2005 Oct; 21(4):232-4. PubMed ID: 16316846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
    Propst AM; Bates GW; Robinson RD; Arthur NJ; Martin JE; Neal GS
    Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal stimulation protocols for in vitro fertilization.
    Muasher SJ; Abdallah RT; Hubayter ZR
    Fertil Steril; 2006 Aug; 86(2):267-73. PubMed ID: 16753157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of microdose flare-up and antagonist multiple-dose protocols for poor-responder patients: a randomized study.
    Demirol A; Gurgan T
    Fertil Steril; 2009 Aug; 92(2):481-5. PubMed ID: 18990368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cumulative pregnancy rates after three cycles of minimal stimulation IVF and results according to subfertility diagnosis: a multicentre cohort study.
    Pelinck MJ; Vogel NE; Hoek A; Simons AH; Arts EG; Mochtar MH; Beemsterboer S; Hondelink MN; Heineman MJ
    Hum Reprod; 2006 Sep; 21(9):2375-83. PubMed ID: 16751647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates.
    Acevedo B; Gomez-Palomares JL; Ricciarelli E; Hernández ER
    Fertil Steril; 2006 Dec; 86(6):1682-7. PubMed ID: 17074344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is long-protocol gonadotropin releasing hormone agonist administration superior to the short protocol in ovarian stimulation for in vitro fertilization?
    Tasdemir M; Tasdemir I; Kodama H; Higuchi M
    Int J Fertil Menopausal Stud; 1995; 40(1):25-8. PubMed ID: 7749431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
    Barrenetxea G; Agirregoikoa JA; Jiménez MR; de Larruzea AL; Ganzabal T; Carbonero K
    Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.